438 related articles for article (PubMed ID: 24101602)
21. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
Hashimoto Y; Matsuoka M
J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
[TBL] [Abstract][Full Text] [Related]
22. Association of GSK3B with Alzheimer disease and frontotemporal dementia.
Schaffer BA; Bertram L; Miller BL; Mullin K; Weintraub S; Johnson N; Bigio EH; Mesulam M; Wiedau-Pazos M; Jackson GR; Cummings JL; Cantor RM; Levey AI; Tanzi RE; Geschwind DH
Arch Neurol; 2008 Oct; 65(10):1368-74. PubMed ID: 18852354
[TBL] [Abstract][Full Text] [Related]
23. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.
Carter CJ
Neurochem Int; 2007 Jan; 50(1):12-38. PubMed ID: 16973241
[TBL] [Abstract][Full Text] [Related]
24. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain.
Barrachina M; Ferrer I
J Neuropathol Exp Neurol; 2009 Aug; 68(8):880-91. PubMed ID: 19606065
[TBL] [Abstract][Full Text] [Related]
26. The
Almkvist O; Graff C
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946903
[TBL] [Abstract][Full Text] [Related]
27. Interaction of Tau with Fe65 links tau to APP.
Barbato C; Canu N; Zambrano N; Serafino A; Minopoli G; Ciotti MT; Amadoro G; Russo T; Calissano P
Neurobiol Dis; 2005 Mar; 18(2):399-408. PubMed ID: 15686969
[TBL] [Abstract][Full Text] [Related]
28. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
29. Variations in the neuropathology of familial Alzheimer's disease.
Shepherd C; McCann H; Halliday GM
Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098
[TBL] [Abstract][Full Text] [Related]
30. [Selected mice models based on APP, MAPT and presenilin gene mutations in research on the pathogenesis of Alzheimer's disease].
Więdłocha M; Stańczykiewicz B; Jakubik M; Rymaszewska J
Postepy Hig Med Dosw (Online); 2012 Jun; 66():415-30. PubMed ID: 22922141
[TBL] [Abstract][Full Text] [Related]
31. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
32. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
[TBL] [Abstract][Full Text] [Related]
33. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
36. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.
Mano T; Nagata K; Nonaka T; Tarutani A; Imamura T; Hashimoto T; Bannai T; Koshi-Mano K; Tsuchida T; Ohtomo R; Takahashi-Fujigasaki J; Yamashita S; Ohyagi Y; Yamasaki R; Tsuji S; Tamaoka A; Ikeuchi T; Saido TC; Iwatsubo T; Ushijima T; Murayama S; Hasegawa M; Iwata A
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9645-E9654. PubMed ID: 29042514
[TBL] [Abstract][Full Text] [Related]
37. A DNA methylation study of the amyloid precursor protein gene in several brain regions from patients with familial Alzheimer disease.
Brohede J; Rinde M; Winblad B; Graff C
J Neurogenet; 2010 Dec; 24(4):179-81. PubMed ID: 20919856
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
39. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
40. Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease.
Yang Y; Tapias V; Acosta D; Xu H; Chen H; Bhawal R; Anderson ET; Ivanova E; Lin H; Sagdullaev BT; Chen J; Klein WL; Viola KL; Gandy S; Haroutunian V; Beal MF; Eliezer D; Zhang S; Gibson GE
Nat Commun; 2022 Jan; 13(1):159. PubMed ID: 35013160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
